drugset / Trial / NCT01477840

Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at Cesarean

NCT01477840 ↗

Parallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether the effect of sublingual misoprostol is better than infusion oxytocin in reduction of blood loss at cesarean deliveries.

Timeline

Start
2012-08
Primary completion
2012-08
Completion
2012-08

Outcome

Met primary endpoint

paper The amount of blood loss was lower in misoprostol group comparing with oxytocin group (608.91 ml vs 673.9 ml) (p = 0.048) PMID 19757270 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 200 ug Other

Indications

No indication recorded.